Lindsay Kilburn

10PUBLICATIONS
78CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2026
Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAFV600E- or BRAFInsT-Mutant Brain Tumors: PNOC002.

|Jul 01, 2026
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

|Feb 09, 2024
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.

Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia

|Nov 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

|Jul 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.

Cassie Kline, Payal Jain, Lindsay Kilburn

|May 12, 2018
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.

Peter E Manley, Tanya Trippett, Amy A Smith

Pageof 2

Frequent Collaborators

4 joint publications

Cassie Kline

4 joint publications

Sarah Leary

3 joint publications

Darren Hargrave

3 joint publications

Dong-Anh Khuong-Quang